Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Ligand. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN107445999A enables high-purity chiral cyclic amines via Rhodium catalysis. Achieve cost reduction in pharmaceutical intermediates manufacturing with scalable technology.
Patent CN104558029A reveals a high-yield synthesis route for bis(dicyclohexylphosphine)alkane ligands, offering significant cost reduction and supply chain reliability for industrial manufacturing.
Patent CN109970795A details a novel iridium catalyst achieving 98% ee. Discover cost reduction in chiral ligand manufacturing and supply chain advantages.
Advanced one-pot synthesis of oxaliplatin via patent CN100540556C. Offers high purity, simplified workflow, and cost reduction in anticancer drug manufacturing.
Novel axially chiral ligand enables high-yield asymmetric synthesis. Reduces costs and improves supply chain reliability for chiral aminoamide manufacturing.
Novel cobalt-catalyzed asymmetric hydrosilylation patent CN116554223A offers high enantioselectivity and cost-effective manufacturing for pharmaceutical intermediates.
Discover the novel bifunctional conversion of dinitro-bipyridine derivatives. This patent-enabled route offers significant cost reduction and supply chain reliability for high-purity pharmaceutical intermediates.
Patent CN113087640B reveals a cost-effective chiral ONO tridentate ligand and cobalt complex, offering scalable solutions for asymmetric synthesis and supply chain optimization.
Patent CN112209967B reveals high-yield ligand synthesis. Offers cost reduction in pharmaceutical intermediates manufacturing and supply chain reliability.
Patent CN111100124A details a novel linear phenanthroline ligand synthesis offering high TON for Heck reactions, ensuring cost-effective and scalable catalyst solutions.
Patent CN114539327B reveals stable P,N,N-ligand for propargyl conversion. Offers supply chain reliability and cost reduction in pharmaceutical intermediates manufacturing.
Patent CN121378129A reveals novel binaphthyl ligands for asymmetric catalysis. Enhance enantioselectivity and streamline pharmaceutical intermediate manufacturing supply chains.
Novel synthesis of binaphthyl NN-dioxide ligands via Pd-catalyzed carbonylation. High yield over 75 percent and purity exceeding 95 percent. Reliable supplier for asymmetric catalysis.
Patent CN109608381B details a high-yield route for NHPI ligands used in MOFs catalysis, offering scalable production for industrial oxidation applications.
Patent CN120554424A reveals a novel ferrocene-based P,N,N-ligand offering superior stability and stereoselectivity for cost-effective pharmaceutical intermediate manufacturing.
Patent CN121085785A reveals ferrocene-based ligands for asymmetric allylic substitution, offering high enantioselectivity and cost reduction in pharmaceutical intermediate manufacturing.
Discover the novel AgOTf-catalyzed synthesis of allyl thiomethyl ethers from olefins and DMSO. A cost-effective, high-yield route for pharmaceutical intermediates.
Patent CN109851634B discloses Yu-Phos ligands for asymmetric catalysis. Enables cost reduction in pharmaceutical intermediate manufacturing with high stereoselectivity.
Patent CN107690436A details improved ruthenium acetate complex synthesis. Enhances supply chain reliability and cost reduction in fine chemical manufacturing.
Patent CN108586528B details a cost-effective BINAP synthesis avoiding noble metals. Ideal for reliable pharma intermediate suppliers seeking scalable routes.